New Proteomic Subfractionation Surfaces – Innovative Technology for the Improved Resolution of Serum Proteins
Poster Jan 10, 2006
Swapan Roy, John Krupey,Matthew Kuruc and Devjit Roy
IntroductionProFACT™ is a new subfractionation methodology designed for comparative proteome analysis. Electrophoretic profiles of serum subfractions demonstrate improved resolution and quantification. Carryover from the three highest abundance serum proteins, Albumin, IgG and Transferrin is minimal. The process starts with a separation platform utilizing a new combination of surface microenvironments substituted with low molecular weight substrates that feature drugbinding motifs.
With the ProFACT™ surface library, undenatured, bioactive proteins can be subfractionated into differential pools. Separations are universal as they do not require prequalified binding knowledge, a key limitation of affinity-type techniques. The surfaces utilized are disposable and adaptable to sample size and scale requirements. A simple bind, wash and elute protocol is completed in 30 to 60 minutes and as elutions are mild and consistent, a direct handoff can be made to subsequent interrogation. The interrogation strategy is adaptable to meet investigative inquiry using ‘bottom-up’ or ‘top-down’ approaches.
Detailed iterative profiling can be applied towards biomarker discovery, disease-state pattern identification, systems biology, or otherwise be useful to reduce sample complexity. The ProFACT™ surface library can potentially be coupled with HPLC, Capillary Electrophoresis, 1 and 2D Electrophoresis, and Mass Spectrometry to expand coverage and sensitivity. As structural modifications of proteins can alter their binding affinities to the surface library, structural differences in sample sets may be inferred upon interpretation of ProFACT™ subfraction profiles.
The data presented herein demonstrate the unique profiling capabilities of each ProFACT™ surface library subfraction and the collective resolution of 69 non-redundant proteins, calibrated and quantified from image analysis of SDS-PAGE profiles. 10 differential protein subfractions can be generated in less than 1 hour, without the need for immuno-depletion. Future investigations will focus on comparing normal and disease state sera.
Characterization of a Type 2 diabetes-associated islet-specific enhancer cluster in STARD10 by genome editing of EndoC-βH1 cellsPoster
Genome-wide association studies (GWAS) have identified more than 100 genetic loci associated with type 2 diabetes. The majority of these are located in the intergenic or intragenic regions suggesting that the implicated variants may alter chromatin conformation. This, in turn, is likely to influence the expression of nearby or more remotely located genes to alter beta cell function. At present, however, detailed molecular and functional analyses are still lacking for most of these variants. We recently analysed one of these loci and mapped five causal variants in an islet-specific enhancer cluster within the STARD10 gene locus. Here, we aimed to understand how these causal variants influence b-cell function by alteration of the chromatin structure of enhancer clusterREAD MORE
P450 Induction in Cryopreserved Hepatocytes from PXR and CAR Nuclear Receptor Knock-out RatsPoster
The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that regulate the expression of phase I (cytochrome P450s), phase II metabolizing enzymes and transporter genes in response to xenobiotics, including prescription drugs.READ MORE
Psychiatric Risk Gene Cacna1c and Early Life Stress: Potential Gene-Environment interactions?Poster
Early life stress (ELS) is highly associated with development of psychopathology
and mood disorders in adulthood. Genetic studies have identified variation in the gene calcium voltage-gated channel subunit alpha1C (CACNA1C) to increase risk for several psychiatric disorders. This poster assessed the expression of Cacna1c following prepubertal stress.
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018